Literature DB >> 2286355

Factor X-activating procoagulant in normal and malignant breast tissue.

K el-Baruni1, I Taylor, S Roath, J L Francis.   

Abstract

Factor X-activating activity (FXAA) was determined by a chromogenic assay in normal and malignant breast tissue. FXAA was found in all tissue (n = 38) irrespective of pathology, and the activity of normal tissue was similar to that of tumours. FXAA correlated with tissue hemoglobin in normal breast (p less than 0.02) but not in tumours. FXAA was markedly reduced by aluminium hydroxide, barium citrate, anti-human factor VII, DFP, PMSF and phospholipase C, but was unaffected by iodoacetamide and mercuric chloride. It is concluded that FXAA is a serine protease with the properties of a tissue factor-factor VII complex. FXAA occurs in normal and malignant breast tissue, although the 'normal' activity may be an artefact of the homogenization process.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2286355     DOI: 10.1002/hon.2900080604

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN: 0278-0232            Impact factor:   5.271


  4 in total

Review 1.  Non-tissue factor procoagulants in cancer cells.

Authors:  S G Gordon; M Chelladurai
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

2.  Tissue procoagulant activity may be important in sustaining metastatic tumour growth.

Authors:  N J Carty; I Taylor; O S Roath; K el-Baruni; J L Francis
Journal:  Clin Exp Metastasis       Date:  1992-05       Impact factor: 5.150

Review 3.  Tissue factor as a tumor procoagulant.

Authors:  L V Rao
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

4.  Procoagulant activity may be a marker of the malignant phenotype in experimental prostate cancer.

Authors:  A S Adamson; P Luckert; M Pollard; M E Snell; M Amirkhosravi; J L Francis
Journal:  Br J Cancer       Date:  1994-02       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.